Kobayashi Pharmaceutical Co., Ltd. (FRA:KOY)
Germany · Delayed Price · Currency is EUR 30.00
-0.20 (-0.66%)
At close: Aug 1, 2025, 10:00 PM CET
The Duckhorn Portfolio Revenue
Kobayashi Pharmaceutical had revenue of 32.61B JPY in the quarter ending March 31, 2025, a decrease of -10.63%. This brings the company's revenue in the last twelve months to 161.72B, down -8.36% year-over-year. In the year 2024, Kobayashi Pharmaceutical had annual revenue of 165.60B, down -4.53%.
Revenue (ttm)
161.72B JPY
Revenue Growth
-8.36%
P/S Ratio
2.30
Revenue / Employee
44.74M JPY
Employees
3,615
Market Cap
2.30B USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 165.60B | -7.86B | -4.53% |
| Dec 31, 2023 | 173.46B | 7.20B | 4.33% |
| Dec 31, 2022 | 166.26B | 11.01B | 7.09% |
| Dec 31, 2021 | 155.25B | 4.74B | 3.15% |
| Dec 31, 2020 | 150.51B | -17.54B | -10.44% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 35.89B |
| Siemens Aktiengesellschaft | 77.82B |
| Deutsche Telekom AG | 120.25B |
| Allianz SE | 109.03B |
| Siemens Energy AG | 37.44B |
| Rheinmetall AG | 10.48B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.84B |
| Deutsche Bank Aktiengesellschaft | 30.07B |